F10 and neoplasm: The perturbation of FXa-driven PAR1 signaling in mice by the administration of FXa-specific inhibitors, rivaroxaban or edoxaban, is also shown to suppress the proliferation of colorectal tumors while accelerating tumor apoptosis [82].